Midazolam, a short-acting benzodiazepine, resets the circadian clock of the hamster

Pharmacology, Biochemistry, and Behavior
B E Wee, F W Turek

Abstract

Treatment with the short-acting benzodiazepine, triazolam, has been found to induce changes in both behavioral and endocrine circadian rhythms in hamsters. The objective of this study was to determine if these effects of triazolam could be generalized to other short-acting benzodiazepines. Therefore, the effects of midazolam on the biological clock of the hamster were examined in detail. A phase-response curve and a dose-response curve were measured to determine the effects of a single intraperitoneal injection of midazolam on the circadian clock of hamsters free-running in constant light. Midazolam injections produced maximal phase advances at circadian time (CT) 6 and 9 and maximal phase delays at CT 15 and 21. Doses of 2.5 mg or larger produced phase shifts that were significantly different from those produced by the vehicle controls. In addition, the phase-shifting effects of midazolam were completely blocked by administration of the benzodiazepine receptor antagonist, RO 15-1788, indicating that the phase-shifting actions of midazolam are mediated via benzodiazepine receptors. These results indicate that the previously reported effects of triazolam on the circadian clock can be generalized to other short-acting benzodiazep...Continue Reading

References

Feb 1, 1989·Journal of Comparative Physiology. A, Sensory, Neural, and Behavioral Physiology·R D SmithF W Turek
Jan 1, 1985·Pharmacopsychiatry·W Haefely
May 7, 1986·Brain Research·M R Ralph, M Menaker
Jan 1, 1988·Journal of Comparative Physiology. A, Sensory, Neural, and Behavioral Physiology·N Mrosovsky
Jan 1, 1987·Chronobiology International
Feb 1, 1985·Cardiologia : bollettino della Società italiana di cardiologia·M FerrariG Cargnelli
Jan 1, 1983·British Journal of Clinical Pharmacology·L Pieri
Jun 29, 1984·Neuroscience Letters·W Haefely
Apr 9, 1981·Nature·W HunkelerW Haefely
Jun 3, 1983·European Journal of Pharmacology·S V Vellucci, R A Webster
Sep 1, 1983·The New England Journal of Medicine·M C Moore-EdeG S Richardson
Oct 1, 1982·Neuropharmacology·S E FileD J Nutt
May 1, 1983·American Journal of Surgery·J D Giesy, T R Hatch
Aug 29, 2003·The Journal of Steroid Biochemistry and Molecular Biology·Fraser M RogersonPeter J Fuller

❮ Previous
Next ❯

Citations

Jan 1, 1991·European Archives of Psychiatry and Clinical Neuroscience·A A BorbélyI Oswald
Mar 1, 1994·Pharmacology, Biochemistry, and Behavior·Z Boulos, T A Houpt
Jan 1, 1996·Pharmacology & Therapeutics·W C Duncan
Jun 14, 2001·The European Journal of Neuroscience·J Schaap, J H Meijer
Jun 19, 1998·British Journal of Sports Medicine·R ManfrediniF Conconi
Mar 18, 2006·Bipolar Disorders·Michael BauerPeter C Whybrow
Jun 28, 2005·The European Journal of Neuroscience·Mariska J VansteenselJohanna H Meijer
Aug 23, 2003·Journal of Biological Rhythms·Mariska J VansteenselJohanna H Meijer
Aug 3, 2002·Leukemia & Lymphoma·Helen A PapadakiGeorge D Eliopoulos
Mar 13, 2020·Physiological Reviews·Jenna R M HarveyAndrea L Meredith
Aug 1, 1994·Chronobiology International·P RedfernJ Waterhouse
Nov 30, 2016·Frontiers in Neuroendocrinology·H Elliott AlbersDaniel L Hummer
Jan 1, 1993·Life Sciences·A M RosatiR Vertua

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.